Search
Close this search box.
Category: Press Releases

AGC Biologics Honored for Innovations in Cell Line Development

Seattle, Oct. 13, 2022 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has been named a 2022 Leading Innovator in Mammalian Cell Line Development for the USA by Acquisition International.

Read More